Automated COVID symptom tracking in Parkinson's Disease
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: C19-IUC-274
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
UK Research and Innovation (UKRI)Principal Investigator
Dr. Ravi VaidyanathanResearch Location
United KingdomLead Research Institution
UK Dementia Research InstituteResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measuresResearch Subcategory
Indirect health impactsSpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Adults (18 and older), Older adults (65 and older)Vulnerable Population
Individuals with multimorbidityOccupations of Interest
Unspecified
Abstract
The impact of COVID-19 is acutely pronounced on patients suffering from Parkinson's Disease (PD) The majority of the 130,000+ UK patients are elderly, can suffer from respiratory complications, anxiety and depression. We propose to accelerate the development of an at-home Parkinson's Diagnostic Device (PDD) addressing this need to assist neurologists in telemedicine examination of PD patients for remote monitoring and subsequent updating of medication plans accordingly.